Effects of mesangium glycation on matrix metalloproteinase activities: Possible role in diabetic nephropathy

Diabetes

Volumn 51, Issue 8, 2002, Pages 2612-2618

  McLennan, S V ^a,b   Martell, S K Y ^a,b   Yue, D K ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; GELATINASE A; GLUCOSE; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GENE EXPRESSION; GLYCATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MESANGIUM; NUCLEOTIDE SEQUENCE; PANCREAS ISLET; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0036323281     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.8.2612     Document Type: Article

References (50)

1. Implications of the Diabetes Control and Complications Trial
2. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial
3. 1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial
4. The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus
5. Control of mammary epithelial differentiation: Basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity
6. Extracellular matrix modulates macrophage functions characteristic to atheroma: Collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro
7. Regulation of extracellular matrix degradation by cell-extracellular matrix interactions
8. Regulation of connective tissue turnover by cell-matrix interactions
9. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells
10. A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype
11. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence
12. Advanced glycation end-products in diabetic nephropathy
13. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications
14. Matrix metalloproteinases and their inhibitors
15. Matrix metalloproteinases
16. Matrix metalloproteinases and their inhibitors in endocrinology
17. Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture
18. Degradation of glomerular basement membrane by purified mammalian metalloproteinases
19. Glomerular injury and proteolytic enzymes
20. Proteinases and the glomerulus: Their role in glomerular diseases
21. The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy
22. Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions
23. Regulation of matrix metalloproteinase activity
24. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells
25. Distinct patterns of collagen gene expression are seen in normal and keloid fibroblasts grown in three-dimensional culture
26. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis
27. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas
28. Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP
29. Transcriptional and post transcriptional regulation of 72kDa gelatinase/typeIV collagenase by transforming growth factor β1 in human fibroblasts
30. Identification and independent regulation of human mesangial cell metalloproteinases
31. High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy
32. Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosyiated matrix
33. Inhibition of angiogenesis on glycated collagen lattices
34. Effect of glucose on matrix metalloproteinase activity in mesangial cells
35. 14C] acetylated collagen
36. Interaction of ascorbic acid and glucose on production of collagen and proteoglycan by fibroblasts
37. Pathophysiology of diabetic nephropathy
38. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells
39. High glucose and TGF beta 1 stimulate fibronectin gene expression through a cAMP response element
40. High glucose activates protein kinase C and stimulates fibronectin gene expression by enhancing a cAMP response element
41. Matrix nonenzymatic glycosylation leads to altered cellular phenotype and intracellular tyrosine phosphorylation
42. Cellular contraction of collagen lattices is inhibited by nonenzymatic glycation
43. High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells: Possible role in mesangium accumulation
44. The C-terminal region of inembrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation
45. Decreased contraction of glycated collagen lattices coincides with impaired matrix metalloproteinase production
46. The transforming growth factor-beta system and the kidney
47. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy
48. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis
49. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes
50. Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy